Emerging Evidence Links Diverse Misfolded Proteins to Alzheimer's and Dementia
New research uncovers over 200 types of misfolded proteins linked to Alzheimer's and dementia, opening new avenues for treatment beyond amyloid plaques.
Recent research from Johns Hopkins University has broadened our understanding of the molecular contributors to Alzheimer's disease and dementia. Traditionally, scientific focus centered on amyloid-beta and tau proteins, which form noticeable plaques disrupting neural functions. However, new findings reveal that over 200 different types of misfolded proteins are involved in age-related cognitive decline, even when they do not aggregate into visible amyloid plaques.
In a study involving aging rats, scientists identified numerous proteins that misfold, with more than 200 showing abnormal shapes in rats exhibiting cognitive deficits. This suggests that protein misfolding is far more complex than previously believed and that these improperly folded proteins may interfere with brain function independently of amyloid formation.
The research highlights that misfolded proteins evade the cellular systems designed to target and destroy damaged proteins, which could explain their detrimental effects despite not forming large clumps. This breakthrough opens new avenues for understanding the molecular mechanisms underpinning cognitive decline and indicates potential targets for innovative therapeutic strategies.
Moving forward, scientists plan to use advanced microscopy to examine the structural deformities of these misfolded proteins at the molecular level. Such insights could lead to the development of treatments aimed at preventing or reversing protein misfolding, thereby preserving cognitive health as individuals age.
This study emphasizes that amyloid buildup may be just one part of a larger picture involving numerous proteins that contribute to neurodegenerative processes. Recognizing and targeting these diverse misfolded proteins could significantly impact future approaches to preventing and treating Alzheimer's and related dementias.
Source: [https://medicalxpress.com/news/2025-07-misfolded-proteins-previously-contribute-alzheimer.html]
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
FDA Resolves Nationwide Shortage of IV Saline Solutions
The FDA has announced the end of the nationwide shortage of IV saline solutions, thanks to coordinated efforts to boost manufacturing and stabilize the supply chain, ensuring patients' access to essential medical supplies.
Insufficient Evidence for Neurosteroid Drugs in Managing Postnatal Depression
Current studies do not conclusively support the use of new neurosteroid drugs like Zuranolone, Brexanolone, and Ganaxolone for postnatal depression. Further research is needed before they can be recommended in clinical practice.
Establishing a National Standard for Safe and Scalable AI in Healthcare
Duke University researchers have developed pioneering frameworks to evaluate the safety and performance of AI models in healthcare, advancing responsible AI adoption with scalable assessment tools for clinical settings.